Unknown PHASE3 INTERVENTIONAL 2-arm NCT00932217

Study on the Incidence of Febrile Episodes During Stem Cells Collection After Chemotherapy in Patients With Multiple Myeloma

Sponsor: University of Pisa

Conditions G-CSF, Multiple Myeloma, Febrile Episode, Filgrastim, Leograstim

Updated 4 times since 2017 Last updated: Jul 2, 2009 Started: Dec 31, 2004 Primary completion: Apr 30, 2007

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE3 trial investigates G-CSF, Multiple Myeloma, Febrile Episode, Filgrastim, Leograstim and is currently ongoing. University of Pisa leads this study, which shows 4 recorded versions since 2004 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE3
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE3

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE3
Jan 2017 — Jan 2021 [monthly]

Unknown Status PHASE3

First recorded

Dec 2004

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University of Pisa

Data source: University of Pisa

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.